Sapience Therapeutics, Inc. Employee Directory

Biotechnology ResearchNew York, United States11-50 Employees

Sapience Therapeutics, Inc. is a biotechnology research company based in Tarrytown, New York, focused on discovering and developing peptide therapeutics to address cancer-related oncogenic and immune dysregulation. Its pipeline targets intracellular protein-protein interactions to affect transcription factors, aiming to treat cancers that have traditionally been difficult to drug, with lead programs ST316 and lucicebtide advancing in Phase 2 clinical trials. The company serves the oncology research and clinical communities seeking novel therapeutic options and contributes to exploring first-in-class approaches that disrupt key regulatory pathways in cancer biology. Sapience positions itself within the biotech sector as a clinical-stage organization developing peptide-based therapeutics, collaborating and presenting at scientific and investor-focused events to share progress. Recent activities include participation in major clinical oncology forums and ongoing updates from Phase 2 studies in glioblastoma, reflecting its therapeutic focus and scientific advancing program trajectory.

Sign up for free to view info

Company overview Email format